0.02
+5.63%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About ALR Technologies SG
Its shares trade under the ticker ALRTF. It has been listed since 13 March 2000. In the fiscal year to 31 December 2023, it reported revenue of $25,536 and a net loss of $7.5m. At that date it held total assets of $155,198 and shareholders' equity of −$31.9m.
ALR Technologies SG Ltd. is a data management company, which engages in providing healthcare management solutions. The company is headquartered in Richmond, Virginia. The company went IPO on 2000-03-13. The firm is engaged in the development of a comprehensive approach to diabetes care that includes a Food and Drug Administration (FDA) cleared diabetes management system (the Diabetes Solution), which collects data directly from blood glucose meters (BGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. The firm has developed the Diabetes Solution for human health, and the GluCurve, a modified version of the Diabetes Solution, for animal health (GluCurve) from its technology portfolio. The firm has developed its Diabetes Solution, which is a comprehensive approach to diabetes care consisting of data collection, predictive A1C, insulin dosage adjustment suggestions, performance tracking, remote monitoring and diabetes test supplies. Its subsidiaries include ALR Technologies SG Pte. Ltd. and Canada Diabetes Solution Centre Inc.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Equipment & Supplies
- Listed since
- 13 Mar 2000
- Employees
- 6
- Website
- alrt.com ↗
- Head office
- 9 RAFFLES PLACE, SINGAPORE, U0, 048619
- Classification
- Surgical & Medical Instruments & Apparatus
- Filer status
- Non-accelerated filer
Leadership
Pay as last reported
- Mr. Soongling ChanChairman of the Board of Directors, Chief Executive Officer, Chief Financial Officer, since 2011$249,600
- Mr. Ronald ChengIndependent Director
- Mr. Kenneth RobulakIndependent Director$559,554
- Dr. Alfonso SalasIndependent Director
- Mr. Peter StaffordIndependent Director$304,692
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- ALR Technologies SG Ltd. employs 6 full-time employees and has a focused healthcare data management approach.
- The Diabetes Solution is FDA cleared for diabetes management and includes blood glucose meter data collection.
- GluCurve is a modified Diabetes Solution for animal health using the same technology portfolio.
Weaknesses
- The company has only 6 employees and limited staff for scaling operations.
- ALR Technologies SG Ltd. has no subsidiaries in the US market beyond Canada Diabetes Solution Centre Inc.
- The company's IPO date of 13 March 2000 is over two decades old.
Opportunities
- The FDA-cleared Diabetes Solution can expand into new healthcare segments for diabetes care.
- GluCurve's animal health application offers a new market opportunity in veterinary care.
- Canada Diabetes Solution Centre Inc. can drive growth in the Canadian healthcare market.
Threats
- The company's small size with 6 employees may limit its ability to compete with larger healthcare data firms.
- ALR Technologies SG Ltd. faces challenges in scaling its operations due to limited workforce.
- The aging IPO date of 13 March 2000 may affect investor interest in the company.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.